Quantification of dopamine transporter density in monkeys by dynamic pet imaging of multiple injections of 11C-CFT

Synapse

Volumn 24, Issue 3, 1996, Pages 262-272

  Morris, Evan D ^a,b   Babich, John W ^a,b   Alpert, Nathaniel M ^a,b   Bonab, Ali A ^a,b   Livni, E ^a,b   Weise, Stephen ^a,b   Hsu, Hongbing ^a,b   Christian, Bradley T ^a,b   Madras, Bertha K ^b   Fischman, Alan J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

B'max; Displacement study; Mathematical model; Parameter estimates; Receptor occupancy

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARRIER PROTEIN; COCAINE DERIVATIVE; DOPAMINE; NEUROTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MALE; MATHEMATICAL MODEL; NERVE DEGENERATION; NERVE ENDING; NONHUMAN; PARKINSON DISEASE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; RHESUS MONKEY;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; CARRIER PROTEINS; CEREBELLUM; COCAINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTOPE LABELING; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, NEUROLOGICAL; MOTOR SKILLS; MPTP POISONING; NEOSTRIATUM; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 10544232278     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199611)24:3<262::AID-SYN9>3.0.CO;2-C     Document Type: Article

References (29)

1. Akaike, H. (1976) An information criterion (AIC). Science, 14:5-9.
2. Boyce, S., Rupiak, N.M.J., Steventon, M.J., and Iverson, S.D. (1990) Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. Neurology, 40: 927-933.
3. Brooks, D.J. (1993) PET Studies on the early and differential diagnosis of Parkinson's disease. Neurology, 43(Suppl 6):S6-S16.
4. 3H]WIN 35,428) in the monkey brain. Synapse, 6: 189-195.
5. Delforge, J., Syrota, A., and Mazoyer, B.M. (1990) Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data. IEEE Trans Biomed. Eng., 37:653-661.
6. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol., 34:423-431.
7. German, D.C., Manaye, K., Smith, W.K., Woodward, D.J., and Spaer, C.B. (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol., 26:507-514.
8. 11C]-CFT and PET in a primate model of parkinsonism. NeuroReport, 3:265-268.
9. 18F]fluoro-DOPA in human positron emission tomographic studies. J. Cereb Blood Flow Metab., 11:898-913.
10. Kaufman, M.J., and Madras, B.K. (1991) Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum. Synapse, 9:43-49.
11. 125I]RTI-55. Synapse, 12:99-111.
12. Kish, S.J., Shannak, K., and Hornykiewicz, O. (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N. Engl. J. Med., 318:876-880.
13. Leenders, K.L., Palmer, A.J., Quinn, N., Clark, J.C., Firnau, G., Garnett, E.S., Nahmias, C., Jones, T., and Marsden, C.D. (1986) Brain dopamine metabolism in patients with Parkinson's measured with positron emission tomography. J. Neurol. Neurosurg. Psychiatry, 49:853-860.
14. Leenders, K.L., Aquilonious, S.M., Bergstrom, K., Bjurling, P., Crossman, A.R., Eckernas, S.A., Gee, A.G., Hartvig, P., Lundquist, H., Langstrom, B., Rimland, A., and Tedroff, J. (1988) Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers. Brain Res., 445:61-67.
15. Leenders, K.L., Salmon, E.P., Tyrrell, P., Perani, D., Brooks, D.J., Sager, H., Jones, T., Marsdon, D., and Frackowiak, R.S.J. (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol., 47:1290-1298.
16. Livni, E., Babich, J.W., and Fischman, A.J. (1994) Robotic Synthesis of F-18 and C-11 radiopharmaceuticals at Massachusetts General Hospital. J Labeled Compounds Radiopharm., Vol. XXXV:552-553.
17. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab., 10:740-747.
18. Madras, B.K. (1994) The dopamine transporter and cocaine abuse: comparison between cocaine congeners and other transport inhibitors [abstr]. Dopamine '94, 36.
19. 3H]2β-carbomethoxy-3β-(4-fluorophenyl) tropane. Mol. Pharmacology, 36:518-524.
20. Mazoyer, B.M., Huesman, R.H., Budinger, T.F., and Knittel, B.L. (1986) Dyanamic PET data analysis. J. Comput. Assist. Tomogr., 10: 645-653.
21. Morris, E.D., Alpert, N.M., and Fischman, A.J. (1995) Design and analysis of three-injection dynamic PET experiments for use with 11-C labeled dopamine transporter ligand in monkeys [abstr]. J. Nucl. Med., 36:186.
22. Morris, E.D., Alpert, N.M., and Fischman, A.J. (in press) Comparison of two compartimental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies. J. Cereb. Blood Flow Metab.
23. Pate, B.D., Kawamata, T., Yamuda, T., McGeer, E.G., Hewitt, K.A., Snow, B.J., Ruth, T.J., and Calne, D.B. (1993) Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices. Ann. Neurol., 34:331-338.
24. Rota Kops, E., Herzog, H., Schmid, A., Holte, S., and Feinendegen, L.E. (1993) Performance characteristics of an eight-ring whole body PET scanner. J. Comput. Assist. Tomogr., 14:437-445.
25. 3H]WIN 35, 428. J. Pharm. Exp. Therap., 257: 954-958.
26. Schneider, J.S., and Kovelowski II, C.J. (1990) Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res., 519:122-128.
27. Seeman, P., and Niznik, H.B. (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J., 4:2737-2744.
28. Vingerhoets, F.J.G., Snow, B.J., Tetrud, J.W., Langston, J.W., Schultzer, M., and Calne, D.B. (1994) Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann. Neurol. 36:765-770.
29. 11C]-WIN 35,428. Synapse, 15:130-142.